EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic function

Tyler F Hill, Anna E Helmers, Rene Yu-Hong Cheng, Swati Singh, Leah J Homad, Parnal Narvekar, Gregory D Asher, Nathan D Camp, Emma R Suchland, Andee R Ott, Malika Hale, Chris D Thouvenel und 5 weitere

Molecular Therapy Advances · 2026-03 · 34 (1) · 201666

DOI: 10.1016/j.omta.2026.201666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-03. Verfasst von Tyler F Hill und 16 weiteren Autor:innen. Beteiligte Einrichtung: University of Washington, Medical Scientist Training Program, Seattle, WA, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institutes of Health National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Engineered plasma cells (ePCs) offer a durable strategy for in vivo delivery of therapeutic antibodies, but standard immunodeficient mouse models lack human immune factors critical for plasma cell survival and function. We utilized a humanized mouse model in which NOD.Cg- Prkdc scid Il2rg tm1Wjl /SzJ (NSG) mice were engrafted with human CD34 + stem cells as recipients for infusions with autologous ePCs. In this setting, ePCs localized to plasma cell niches and stably secreted antibodies for over three months. To improve the selection of antibodies for secretion, we developed a B cell receptor surface display screen that identified candidate antibody sequences with high secretion potential. An anti-SARS-CoV-2 antibody (clone 297) selected by this method showed robust secretion both in vitro and vivo, and serum from ePC-engrafted mice potently neutralized SARS-CoV-2 pseudovirus. Together, these findings establish a physiologically relevant model for testing human ePCs, and offer a generalizable strategy for optimizing antibody selection to support long-term therapeutic delivery.

Schlagwörter

Stichwörter der Autor:innen

CRISPRadoptive transferantibody secretionePCsengineered B cellsgene editinghumanized micemonoclonal antibodiesplasma cellssurface display

Autor:innen und Institutionen

  • University of Washington, Medical Scientist Training Program, Seattle, WA, USA.
  • Seattle Children's Research Institute, Center for Immunity and Immunotherapy, Seattle, WA, USA.
  • Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
  • University of Washington, Departments of Global Health and Lab Medicine and Pathology, Seattle, WA, USA.
  • University of Washington, Departments of Pediatrics and Immunology, Seattle, WA, USA.
  • University of Washington, Departments of Pediatrics and Pharmacology, Seattle, WA, USA.

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institutes of Health National Institute of Allergy and Infectious Diseases
  • National Cancer Institute
  • Seattle Children's Research Institute
  • National Institutes of Health

Zitieren

APA

Hill, T. F., Helmers, A. E., Yu-Hong Cheng, R., Singh, S., Homad, L. J., Narvekar, P., Asher, G. D., Camp, N. D., Suchland, E. R., Ott, A. R., Hale, M., Thouvenel, C. D., Stoffers, C. M., Lachkar, S., McGuire, A. T., Rawlings, D. J., & James, R. G. (2026). Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic function. Molecular Therapy Advances, 34(1), 201666. https://doi.org/10.1016/j.omta.2026.201666

Vancouver

Hill TF, Helmers AE, Yu-Hong Cheng R, Singh S, Homad LJ, Narvekar P, et al. Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic function. Molecular Therapy Advances. 2026;34(1):201666. doi:10.1016/j.omta.2026.201666

BibTeX
@article{Hill2026,
  author = {Hill, Tyler F and Helmers, Anna E and Yu-Hong Cheng, Rene and Singh, Swati and Homad, Leah J and Narvekar, Parnal and Asher, Gregory D and Camp, Nathan D and Suchland, Emma R and Ott, Andee R and Hale, Malika and Thouvenel, Chris D and Stoffers, Claire M and Lachkar, Stefan and McGuire, Andrew T and Rawlings, David J and James, Richard G},
  title = {Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic function},
  journal = {Molecular Therapy Advances},
  year = {2026},
  volume = {34},
  number = {1},
  pages = {201666},
  doi = {10.1016/j.omta.2026.201666}
}
Kostenlos starten →